Quanterix (QTRX) Osake Kurssi
Quanterix Kurssi
Liikevaihto on kasvanut 27,5 % vuodessa viimeisten 10 vuoden aikana 138,65 M USD:een. Quanterixn nettomarginaali on nyt −77,3 %, laskenut −52,2 %:sta muutama vuosi sitten. Analyytikoiden mediaanitavoitehinta on 3,00 USD, eli yli nykyhintaa 3,3 %. 8 analyytikosta 0 suosittaa ostoa — kokonaiskonsensus on Pidä.
Quanterix osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Quanterix liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Quanterix -osakkeesta
The business model of Quanterix Corp focuses on developing and commercializing ultra-sensitive biomarker detection systems. By leveraging their proprietary Simoa technology, the company aims to provide researchers and clinicians with the tools necessary to advance precision medicine and improve the detection and treatment of various diseases. Quanterix Corp's cutting-edge platforms enable the measurement of previously undetectable biomarkers, opening up new possibilities in diagnostics, drug development, and personalized healthcare. With their dedication to innovation and pushing the boundaries of detection, Quanterix Corp strives to make a significant impact in the field of life sciences and transform the way diseases are diagnosed and monitored.
Quanterix Corp is primarily active in the life sciences and diagnostics industries.
The main competitors of Quanterix Corp in the market are companies like Bio-Techne Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, and Merck KGaA.
Quanterix Corp is a renowned biotechnology company founded in 2007. With its headquarters in Billerica, Massachusetts, the company specializes in developing ultra-sensitive analysis platforms, known as Simoa, for studying and measuring various biomarkers in life sciences. Quanterix Corp has revolutionized the field of biomarker analysis by enabling detection at previously unattainable levels, enabling breakthroughs in diagnostics, precision medicine, and life sciences research. The company's unparalleled technology has attracted collaborations with prominent academic institutions, pharmaceutical companies, and clinical laboratories worldwide. Quanterix Corp's commitment to innovation and improving patient outcomes has positioned it as a leading player in the field of precision health.
Quanterix Corp has achieved several significant milestones since its inception. The company's groundbreaking Simoa technology has revolutionized the field of ultra-sensitive biomarker analysis, enabling researchers to detect and measure extremely low levels of proteins and biomarkers. Quanterix Corp has also developed a strong portfolio of diagnostic tests for various diseases and conditions, such as neurodegenerative diseases, oncology, and infectious diseases. Moreover, the company has received numerous accolades and recognitions for its innovative approach, including being named a Technology Pioneer by the World Economic Forum. Quanterix Corp continues to advance in its mission to improve healthcare outcomes through cutting-edge diagnostics and precision medicine.
Quanterix Corp is primarily present in the United States and Europe.
Quanterix Corp represents values of innovation, precision, and dedication to advancing science and healthcare. With a strong corporate philosophy focused on transforming medicine through their proprietary technology, they strive to revolutionize diagnostics and biomarker analysis. Quanterix Corp is committed to developing highly sensitive biomarker detection solutions that enable researchers and clinicians to detect diseases far earlier and more accurately than previously possible. Continuously pushing the boundaries of scientific knowledge, Quanterix Corp's pioneering approach has the potential to improve patient outcomes and revolutionize the way healthcare industry operates.
Analyytikot asettavat tällä hetkellä Quanterix-osakkeelle keskimääräisen tavoitehinnan 3,00 USD (mediaani: 3,00 USD), mikä merkitsee +3,3 % viimeisimpään hintaan verrattuna. Konsensus perustuu 8 analyytikkoarvioon.
8 analyytikkoa arvioi tällä hetkellä Quanterix-osaketta: 0 suosittaa ostoa, 5 pitoa ja 3 myyntiä. Vuodelle 2026 analyytikot odottavat Quanterix-yhtiöltä 143,36 M USD liikevaihtoa ja −2,04 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Quanterix-osake noteerataan hintaan 2,60 EUR (2,90 USD).
Quanterix-osake (QTRX) on listattuna 1 pörssissä, muun muassa: NASDAQ (QTRX).
Quanterix Corp is a company that specializes in the development and sale of instruments and reagents for digital diagnostic applications. It is working on developing technologies that increase the accuracy and sensitivity of tests, enabling better disease diagnosis and monitoring. The company's business model is based on three main divisions: instruments, reagents, and services. They offer automated systems that can conduct biomarker analysis at the single-molecule level. The company also provides training and consulting services for the use of their instruments and reagents. They are known for their Simoa technology, which is used for disease diagnosis based on the measurement of biomarkers in blood. Quanterix Corp works closely with leading companies in the life science industry to integrate their technology into their products. Overall, the company is recognized as a key player in the field of digital diagnostics.
odotettu liikevaihto Quanterix on 143,36 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Quanterix on −95,51 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Quanterix:n hinta-voitto-suhde (P/E) on tällä hetkellä −1,42. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Quanterix-osakkeen arvostusta.
Quanterix:n hinta-myynti-suhde (P/S) on tällä hetkellä 0,95. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Quanterix-osakkeen arvostuskennuslukuna.
Quanterix:n Eulpool-laatuscore on 5/10.
Quanterix:n ISIN on US74766Q1013. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Quanterix:n WKN on A2H9FB. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Quanterix:n ticker on QTRX. Tämä pörssinoteeraus käytetään Quanterix-osakkeiden kauppaan pörssissä.
Quanterix osake
Quanterix vertaisryhmä
Quanterix Ticker
Quanterix FIGI
Kaikki tunnusluvut ja syvällinen analyysi Quanterix:sta
Meidän osakeanalyysimme Quanterix-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Quanterix:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: